Related references
Note: Only part of the references are listed.Therapeutic efficacy and toxicity of tamoxifen loaded PLA nanoparticles for breast cancer
Sanjeev K. Pandey et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
Docetaxel load biodegradable porous microspheres for the treatment of colorectal peritoneal carcinomatosis
RangRang Fan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2014)
Sulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinoma
Xiao Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Monolayer-capped gold nanoparticles for disease detection from breath
Morad K. Nakhleh et al.
NANOMEDICINE (2014)
LRIG1 as a Potential Novel Marker for Neoplastic Transformation in Ocular Surface Squamous Neoplasia
Maho Nagata et al.
PLOS ONE (2014)
LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2
Xu-chen Qi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor
Y. Wang et al.
BRITISH JOURNAL OF CANCER (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma
Susanne Muller et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
A role for LRIG1 in the regulation of malignant glioma aggressiveness
Feng Mao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Estimated Disability-adjusted Life Year (DALY) in Asia in GLOBOCAN 2008
Ryoko Machii et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2013)
LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development
Liwen Lu et al.
JOURNAL OF PATHOLOGY (2013)
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
Mikael Johansson et al.
NEURO-ONCOLOGY (2013)
LRIG1 Modulates Cancer Cell Sensitivity to Smac Mimetics by Regulating TNFα Expression and Receptor Tyrosine Kinase Signaling
Longchuan Bai et al.
CANCER RESEARCH (2012)
Differential efficacy of DOTAP enantiomers for siRNA delivery in vitro
Megan Cavanaugh Terp et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Dual-purpose magnetic micelles for MRI and gene delivery
Chunyan Wang et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA
Ditte Krohn Jensen et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Diclofenac/biodegradable polymer micelles for ocular applications
Xingyi Li et al.
NANOSCALE (2012)
Dextran-g-PEI nanoparticles as a carrier for co-delivery of adriamycin and plasmid into osteosarcoma cells
Kuo Sun et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2011)
Novel cationic 6-lauroxyhexyl lysinate modified poly(lactic acid)-poly(ethylene glycol) nanoparticles enhance gene transfection
Chunxi Liu et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2011)
Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system
Sa-Won Lee et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy
Xian-Zhu Yang et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Truncated bFGF-Mediated Cationic Liposomal Paclitaxel for Tumor-Targeted Drug Delivery: Improved Pharmacokinetics and Biodistribution in Tumor-Bearing Mice
Xianhuo Wang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Preparation of curcumin loaded poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) nanofibers and their in vitro antitumor activity against Glioma 9L cells
Gang Guo et al.
NANOSCALE (2011)
Cationic Solid Lipid Nanoparticles Loaded by Cysteine Proteinase Genes as a Novel Anti-Leishmaniasis DNA Vaccine Delivery System: Characterization and In Vitro Evaluations
Delaram Doroud et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2010)
Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity
Fei Ye et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Suppression of the Negative Regulator LRIG1 Contributes to ErbB2 Overexpression in Breast Cancer
Jamie K. Miller et al.
CANCER RESEARCH (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Intermediates in the refolding of urea-denatured dimeric arginine kinase from Stichopus japonicus
Guo Qin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2007)
Targeted gene-delivery strategies for angiostatic cancer treatment
Ricardo J. M. G. E. Brandwijk et al.
TRENDS IN MOLECULAR MEDICINE (2007)
LRIG1 expression in colorectal cancer
Ingrid Ljuslinder et al.
ACTA ONCOLOGICA (2007)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Design of modular non-viral gene therapy vectors
L De Laporte et al.
BIOMATERIALS (2006)
Effective gene therapy with nonintegrating lentiviral vectors
RJ Yáñez-Muñoz et al.
NATURE MEDICINE (2006)
Towards safe, non-viral therapeutic gene expression in humans
DJ Glover et al.
NATURE REVIEWS GENETICS (2005)
Nanoparticle based systemic gene therapy for lung cancer: Molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response
B Gopalan et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2004)
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim et al.
CLINICAL CANCER RESEARCH (2004)
Progress and problems with the use of viral vectors for gene therapy
CE Thomas et al.
NATURE REVIEWS GENETICS (2003)
Cationic microparticles: A potent delivery system for DNA vaccines
M Singh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
